Market Tracker

10/24 6:05pm ET

Theravance Inc (NASDAQ:THRX)

17.08
Data as of Oct 24
 -0.09 / -0.52%
Today’s Change
15.76
Today|||52-Week Range
32.88
-40.52%
Year-to-Date

Today’s Trading

Previous close17.17
Today’s open17.17
Day’s range16.80 - 17.29
Volume624,306
Average volume (3 months)798,259
Market cap$2.0B
Dividend yield5.85%
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+35.24%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book6.37

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...0.000.00%
CLVSClovis Oncology Inc+1.53+2.83%
IRWDIronwood Pharmaceuti...-0.04-0.30%
RCPTReceptos Inc+2.90+4.50%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 31, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts